150 related articles for article (PubMed ID: 30426827)
21. Septal granulomatous panniculitis in Sweet's syndrome. Report of two cases.
Blaustein A; Moreno A; Noguera J; de Moragas JM
Arch Dermatol; 1985 Jun; 121(6):785-8. PubMed ID: 4004303
[TBL] [Abstract][Full Text] [Related]
22. Ponatinib-induced neutrophilic panniculitis.
Zhang M; Hassan KM; Musiek A; Rosman IS
J Cutan Pathol; 2014 Jul; 41(7):597-601. PubMed ID: 24602068
[TBL] [Abstract][Full Text] [Related]
23. Neutrophilic panniculitis.
Sutra-Loubet C; Carlotti A; Guillemette J; Wallach D
J Am Acad Dermatol; 2004 Feb; 50(2):280-5. PubMed ID: 14726888
[TBL] [Abstract][Full Text] [Related]
24. A Case of Sweet's Panniculitis Associated with Spinal Metastasis from Prostate Cancer.
Kim J; Choi YJ; Oh SH; Lee KH
Ann Dermatol; 2010 Nov; 22(4):478-81. PubMed ID: 21165226
[TBL] [Abstract][Full Text] [Related]
25. Sweet's panniculitis.
Cullity J; Maguire B; Gebauer K
Australas J Dermatol; 1991; 32(2):61-4. PubMed ID: 1781756
[TBL] [Abstract][Full Text] [Related]
26. Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib.
Finelt N; Lulla RR; Melin-Aldana H; Ruth JS; Lin FY; Su JM; Pourciau CY; Hunt RD; Kenner-Bell BM
Pediatr Dermatol; 2017 May; 34(3):337-341. PubMed ID: 28523881
[TBL] [Abstract][Full Text] [Related]
27. Histiocytoid Sweet's syndrome in a patient with myelodsyplastic syndrome: report and review of the literature.
Shalaby MM; Riahi RR; Rosen LB; Soine EJ
Dermatol Pract Concept; 2016 Jan; 6(1):9-13. PubMed ID: 26937301
[TBL] [Abstract][Full Text] [Related]
28. Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma.
Pattanaprichakul P; Tetzlaff MT; Lapolla WJ; Torres-Cabala CA; Duvic M; Prieto VG; Tsai KY; Curry JL
J Cutan Pathol; 2014 Mar; 41(3):326-8. PubMed ID: 24372055
[No Abstract] [Full Text] [Related]
29. Acute infectious id panniculitis/panniculitic bacterid: a distinctive form of neutrophilic lobular panniculitis.
Magro CM; Dyrsen ME; Crowson AN
J Cutan Pathol; 2008 Oct; 35(10):941-6. PubMed ID: 18681863
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature.
Chan MP; Duncan LM; Nazarian RM
J Am Acad Dermatol; 2013 Jun; 68(6):1006-15. PubMed ID: 23399459
[TBL] [Abstract][Full Text] [Related]
31. Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report.
Hashemi SM; Fazeli SA; Vahedi A; Golabchifard R
Mol Clin Oncol; 2016 Mar; 4(3):436-440. PubMed ID: 26998300
[TBL] [Abstract][Full Text] [Related]
32. Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor.
Galliker NA; Murer C; Kamarashev J; Dummer R; Goldinger SM
Eur J Dermatol; 2015 Apr; 25(2):177-80. PubMed ID: 25788221
[TBL] [Abstract][Full Text] [Related]
33. BRAFi-associated panniculitis - an emerging side effect with a variable histological picture: report of two cases and review of the literature.
Ferreira J; Toda-Brito H; Moura MC; Sachse MF; Costa-Rosa J
J Cutan Pathol; 2017 Mar; 44(3):307-309. PubMed ID: 27976808
[No Abstract] [Full Text] [Related]
34. Cutaneous granulomatous panniculitis and sarcoidal granulomatous papular eruption in a patient with metastatic melanoma treated with a BRAF inhibitor.
Leal L; Agut-Busquet E; Romani J; Sabat M; Yebenes M; Saez A; Luelmo J
J Dermatol; 2016 Jun; 43(6):715-6. PubMed ID: 26777901
[No Abstract] [Full Text] [Related]
35. Vemurafenib-induced panniculitis.
Villani AP; Zaharia D; Dalle S; Depaepe L; Balme B; Thomas L
Eur J Dermatol; 2013 Apr; 23(2):258-60. PubMed ID: 23567624
[No Abstract] [Full Text] [Related]
36. Sweet's syndrome in the setting of CD34-positive acute myelogenous leukemia treated with granulocyte colony stimulating factor: evidence for a clonal neutrophilic dermatosis.
Magro CM; De Moraes E; Burns F
J Cutan Pathol; 2001 Feb; 28(2):90-6. PubMed ID: 11168757
[TBL] [Abstract][Full Text] [Related]
37. Neutrophilic Infiltrates in Panniculitis: Comprehensive Review and Diagnostic Algorithm Proposal.
Llamas-Velasco M; Fraga J; Sánchez-Schmidt JM; Fernández-Figueras M; Gallardo F; Rütten A; Kempf W
Am J Dermatopathol; 2020 Oct; 42(10):717-730. PubMed ID: 32956080
[TBL] [Abstract][Full Text] [Related]
38. Acute neutrophilic myositis in Sweet's syndrome: late phase transformation into fibrosing myositis and panniculitis.
Attias D; Laor R; Zuckermann E; Naschitz JE; Luria M; Misselevitch I; Boss JH
Hum Pathol; 1995 Jun; 26(6):687-90. PubMed ID: 7774902
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic, Immunohistochemical, and Molecular Features of Histiocytoid Sweet Syndrome.
Alegría-Landa V; Rodríguez-Pinilla SM; Santos-Briz A; Rodríguez-Peralto JL; Alegre V; Cerroni L; Kutzner H; Requena L
JAMA Dermatol; 2017 Jul; 153(7):651-659. PubMed ID: 28296991
[TBL] [Abstract][Full Text] [Related]
40. Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy.
Consoli F; Manganoni AM; Grisanti S; Petrelli F; Venturini M; Rangoni G; Guarneri F; Incardona P; Vermi W; Calzavara Pinton PG; Berruti A
PLoS One; 2019; 14(4):e0214884. PubMed ID: 30939167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
